88IV - PR Newswire Asia's news - Medical/Pharmaceuticals


Datasea's Five AI Agent Customer Arrangements Reach Approximately US$4.0 Million in Aggregate Service Value Aggregate service value increased approximately 264% from the approximately US$1.10 million disclosed in mid-September; continued execution advances AI agent commercialization under arrangements previously ... 2026-10-13T Computer Software Computer/Electronics Internet Technology Medical/Pharmaceuticals
AI-driven Molecular Glue Innovation: Insilico Nominates ISM9546, an Oral, Peripheral-Restricted VAV1 Degrader as PCC for Autoimmune Diseases Sustained Boost in AI-Driven R&D Productivity : ISM9546 marks Insilico Medicine's 35th preclinical candidate (PCC) nominated since 2021 and its 11th PCC within the first 10 months of 2026 alone, setting ... 2026-10-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ailux Appoints Lloyd S. Miller, M.D., Ph.D., as Chief Medical Officer Dr. Miller will lead the advancement of the company's AI-native biologics toward first-in-human trials, with initial clinical entry targeted for 2027 He will also establish a U.S. clinical and research ... 2026-10-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Kelun-Biotech to Present Multiple Study Results at ESMO 2026 CHENGDU, China , Oct. 13, 2026 /PRNewswire/ -- The 2026 European Society for Medical Oncology (ESMO) Congress will be held in Madrid, Spain, from October 23 to 27. Sichuan Kelun-Biotech Biopharmaceutical ... 2026-10-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Hiteck Licenses Investigational Next-Generation NGF Eye Drop HT006.2.2 to Visara for Neurotrophic Keratitis Outside Greater China Hiteck grants Visara, a majority-owned ophthalmology subsidiary of NovaBridge Biosciences (NASDAQ: NBP), exclusive worldwide rights, excluding Greater China, to develop and commercialize HT006.2.2 ... 2026-10-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
The Right Doctor Isn't Always One Doctor Why complex brain and spine conditions increasingly call for specialists to work across disciplines. ... 2026-10-13T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Rona Therapeutics enters into global license agreement with Roche for ALK7-targeting RNAi therapy for obesity and metabolic diseases SANTA BARBARA, Calif. , Oct. 13, 2026 /PRNewswire/ -- Rona Therapeutics today announced it has granted Roche (SIX: RO, ROG; OTCQX: RHHBY) an exclusive worldwide license for Rona's investigational RNAi ... 2026-10-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
World Thrombosis Day campaign urges global action to protect women against blood clots Global campaign brings together partners to raise awareness of women's unique blood clot risks, recognize warning signs and take action to prevent life-threatening events. ... 2026-10-13T Health Care/Hospital Medical/Pharmaceuticals
ArkBio Announces FDA Clearance to Initiate Phase II Trial of AK0406 for Influenza Prevention SHANGHAI , Oct. 13, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the U.S. Food and Drug Administration (FDA) has granted its investigational ... 2026-10-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
GCCL and LabConnect Sign MOU to Expand Global Clinical Trial Collaboration Linking North American and Asia-Pacific Capabilities to Support Joint Sales and Project Execution ... 2026-10-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Medical/Pharmaceuticals